Determination of Lovastatin, β-glucan, Total Polyphenols, and Antioxidant Activity in Raw and Processed Oyster Culinary-Medicinal Mushroom, Pleurotus ostreatus (Higher Basidiomycetes).
The objective of this study was to quantify a number of bioactive compounds and antioxidant activity of the oyster mushroom, Pleurotus. Ostreatus, and characterize the effects of processing, such as blanching, on these outcomes. Dry matter content was 8%. Lovastatin was not detected in this study. β-glucan content of 23.9% and total polyphenol content of 487.12 mg gallic acid equivalent/100 g of dry matter were obtained in raw P. ostreatus. Antioxidant activities as evaluated by 1,1-diphenyl-2-picrylhydrazyl, Trolox equivalent antioxidant capacity, and ferric reducing antioxidant power assays in raw P. ostreatus were 14.46, 16.51, and 11.21 µmol/g, respectively. Blanching did not significantly affect β-glucan content but caused significant decrease in dry matter content, polyphenol content, and antioxidant activities. Mushroom rolls produced from blanched mushrooms and blanching water contained significantly higher amounts of β-glucan, total polyphenol content, and FRAP antioxidant activity compared to blanched mushrooms. In conclusion, P. ostreatus is a good source for β-glucan, dietary polyphenols, and antioxidants. Although the blanching process could affect these properties, re-addition of the blanching water during the production process of mushroom rolls could potentially recover these properties and is therefore recommended.
Human Nutrition Research Centre, School of Agriculture, Food and Rural Development, Newcastle University, Newcastle upon Tyne, NE1 7RU, United Kingdom.
Yu Shan
YS
Lam
Human Nutrition Research Centre, School of Agriculture, Food and Rural Development, Newcastle University, Newcastle upon Tyne, NE1 7RU, United Kingdom.
Edward J
EJ
Okello
D000363:Agaricales; D000975:Antioxidants / Q000032:analysis / Q000494:pharmacology*; D001688:Biological Products / Q000494:pharmacology*; D001713:Biphenyl Compounds / Q000378:metabolism; D062610:Fungal Polysaccharides / Q000032:analysis / Q000494:pharmacology*; D008148:Lovastatin / Q000032:analysis / Q000494:pharmacology*; D010084:Oxidation-Reduction; D010851:Picrates / Q000378:metabolism; D020076:Pleurotus / Q000737:chemistry*; D059808:Polyphenols / Q000032:analysis / Q000494:pharmacology*; D047071:beta-Glucans / Q000032:analysis / Q000494:pharmacology*
D000975:Antioxidants; D001688:Biological Products; D001713:Biphenyl Compounds; D062610:Fungal Polysaccharides; D010851:Picrates; D059808:Polyphenols; D047071:beta-Glucans; D008148:Lovastatin; C004931:1,1-diphenyl-2-picrylhydrazyl